Transforming cannabis into scientifically proven and clinically approved medical solutions
OWC Pharmaceutical Research Corp. realizes the potential of medical cannabis research and develops pharmaceutical products, specifically designed to improve the lives of millions.
Through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., the company conducts medical research and clinical trials to develop cannabis-based novel therapeutic products and treatments, and develops unique and effective delivery systems and dosage forms of medical cannabis for diverse medical conditions including multiple myeloma, psoriasis, fibromyalgia and PTSD.
The company’s research is conducted at the facilities of leading Israeli academic medical centers and scientific institutes, and is led by internationally renowned investigators.
Our multi-disciplinary team of experts delivers years of proven experience in medical science and regulatory affairs, as well as extensive experience in diverse cannabis-related topics.
OWCP’s Intellectual Property Portfolio comprises the following:
OWC Pharmaceutical Research is traded on the OTCQB market –